Causes of NASH
NASH develops from a complex interplay of metabolic dysfunction, genetic susceptibility, and lipotoxic injury, with obesity, insulin resistance, and type 2 diabetes being the primary drivers that create a vulnerable hepatic environment for progression from simple steatosis to inflammatory liver injury. 1
Primary Metabolic Drivers
The fundamental causes of NASH center on cardiometabolic disorders that create hepatic fat accumulation and subsequent injury 1:
- Obesity - particularly central/visceral adiposity
- Insulin resistance - the reproducible pathogenic factor that favors free fatty acid accumulation in the liver 2
- Type 2 diabetes mellitus - present in 2-3 fold higher risk for NASH 1
- Atherogenic dyslipidemia - hypertriglyceridemia and abnormal lipid metabolism
- Hypertension - part of the metabolic syndrome constellation
These conditions collectively represent NASH as the hepatic manifestation of metabolic syndrome (syndrome X), with 25% of the global population having NAFLD and approximately 12-14% of those progressing to NASH 1.
Pathogenic Mechanisms: The "Multiple-Hit" Hypothesis
The progression from simple steatosis to NASH involves several concurrent pathogenic processes 3, 4:
Lipotoxicity (Primary Driver)
Free fatty acid metabolites cause endoplasmic reticulum stress, hepatocyte apoptosis, necrosis and inflammation - this lipotoxicity model has replaced the older "two-hit" hypothesis 3. Paradoxically, triglyceride accumulation may actually be protective against hepatocellular injury 3.
Oxidative Stress Pathways
- CYP2E1 induction - catalyzes microsomal lipid peroxidation and is invariably increased in NASH livers 2
- Mitochondrial dysfunction - impaired beta-oxidation leads to reactive oxygen species generation
- De novo lipogenesis - excessive hepatic lipid synthesis worsens steatosis 3
Inflammatory Cascade
Hepatocellular injury triggers secondary inflammation and fibrogenesis, with products of the inflammatory infiltrate playing crucial roles in progression to cirrhosis 2.
Genetic Susceptibility
Genetic variants significantly modify NASH risk 5, 3:
- PNPLA3 variant (I148M/rs738409) - strongly associated with increased hepatic fat content and inflammation, found at higher frequency in Hispanic populations (explaining their increased susceptibility) 3
- HSD17B13 variants - currently being targeted in clinical trials 5
- Family history of diabetes - independent risk factor 3
Secondary and Contributing Causes
Beyond primary metabolic dysfunction, several secondary factors can cause or exacerbate NASH 6:
Medications (Macrovesicular Steatosis)
- Amiodarone
- Methotrexate
- Tamoxifen
- Corticosteroids
- Valproate and antiretrovirals
Surgical/Nutritional
- Jejunoileal bypass surgery
- Rapid profound weight loss in obese subjects
- Total parenteral nutrition
- Nutritional protein deficiency 7
Other Medical Conditions
- Hypothyroidism
- Hypopituitarism
- Hypogonadism
- Sleep apnea
- Polycystic ovary syndrome 6
Lifestyle Factors
Modern lifestyle represents the most relevant modifiable factor 8:
- Sedentary behavior with low physical activity
- Poor dietary patterns - high in saturated fat, refined carbohydrates, fructose (especially high-fructose corn syrup), and sugar-sweetened beverages
- Excess caloric intake leading to positive energy balance
Critical Clinical Pitfalls
Important caveats to avoid misdiagnosis:
Alcohol consumption must be excluded - defined as >21 standard drinks/week in men and >14 drinks/week in women over 2 years 9, 10
Hepatitis C (genotype 3) can cause steatosis and must be ruled out 11
Normal liver enzymes do NOT exclude NASH - relentless progression can occur despite consistently normal ALT 12
Age, male gender, and Hispanic ethnicity increase risk independent of other factors 6
The interplay between gut microbiota, innate immune system, adipose tissue, and liver through pathways like the farnesoid X receptor (FXR) adds additional complexity to NASH pathogenesis 3, though these represent areas of ongoing investigation rather than established causative factors requiring clinical action.